the government discloses all the companies with import or manufacture license
the most interesting feature is market cap - Cann now is close to 200 Million
AC8 (AusCan) is most interesting - also backed by big Canadian player (Canopy Growth) but market cap only circa 50-60 Mill. NOt widely reported in Aus but Canopy Growth just did placement of 10% to Constelation Brands (Corona etc) for 200 Mill. Given backing and similar progress to delivering first crops in 2018 I think the buy AC8/Sell CAN trade is worth considering
The other name with import arrangments via Health House is CPH - also with Canadian interests also market cap of under 5o Mill
The big Canadian names with circa 2 Bill market caps have sales of less than 50 Mill
The Aus names who actually succeed getting product to market in next year will probably have that sort of revenue within 18 months
It is hard to find an obvious comparison in opportunity that some of these names have in Australia
My pics AC8; CPH; CAN and MMJ will probably be there as well
